Epithelial sodium channel inhibition in primary human bronchial epithelia by transfected siRNA

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 2, 2009, Pages 211-216

  Caci, Emanuela ^a   Melani, Raffaella ^a   Pedemonte, Nicoletta ^a   Yueksekdag, Guelnihal ^b   Ravazzolo, Roberto ^a   Rosenecker, Joseph ^b   Galietta, Luis J V ^a   Zegarra Moran, Olga ^a  

^a G GASLINI INSTITUTE   (Italy)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Function; Membrane proteins; mRNA

Indexed keywords

ALPHA EPITHELIAL SODIUM CHANNEL; EPITHELIAL SODIUM CHANNEL; GAMMA EPITHELIAL SODIUM CHANNEL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CFTR PROTEIN, HUMAN; CHLORIDE; SODIUM; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BRONCHUS MUCOSA; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG FIBROSIS; LUNG FLUID; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; BIOSYNTHESIS; BRONCHUS; CELL CULTURE; CYSTIC FIBROSIS; EPITHELIUM CELL; GENETIC TRANSFECTION; GENETICS; ION TRANSPORT; METABOLISM; MUTATION; PATHOLOGY; TIME;

BRONCHI; CELLS, CULTURED; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOWN-REGULATION; EPITHELIAL CELLS; EPITHELIAL SODIUM CHANNEL; HUMANS; ION TRANSPORT; MUTATION; RNA, SMALL INTERFERING; SODIUM; TIME FACTORS; TRANSFECTION;

EID: 59149088885     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0456OC     Document Type: Article

References (28)

1. Boucher RC. Human airway ion transport: part one. Am J Respir Crit Care Med 1994;150:271-281.
2. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95:1005-1015.
3. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
4. Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004;10:487-493.
5. App EM, King M, Helfesrieder R, Kohler D, Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease: a rational approach to cystic fibrosis therapy. Am Rev Respir Dis 1990;141:605- 612.
6. Lindemann H, Becker T, Bittner P, Boldt A, Hofmann T, Schwandt HJ. [Elimination of secretions in CF patients under amiloride inhalation.] Pneumologie 1990;44:1148-1150. (in German.)
7. Hofmann T, Senier I, Bittner P, Huls G, Schwandt HJ, Lindemann H. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis. J Aerosol Med 1997;10:147-158.
8. Hirsh AJ, Sabater JR, Zamurs A, Smith RT, Paradiso AM, Hopkins S, Abraham WM, Boucher RC. Evaluation of second generation amilor- ide analogs as therapy for cystic fibrosis lung disease. J Pharmacol Exp Ther 2004;311:929-938.
9. Schutze N. Sirna technology. Mol Cell Endocrinol 2004;213:115-119.
10. Galietta LJV, Lantero S, Gazzolo A, Sacco O, Romano L, Rossi GA, Zegarra-Moran O. An improved method to obtain highly differenti ated monolayers of human bronchial epithelial cells. In Vitro Cell Dev Biol Anim 1998;34:478-481.
11. Galietta LJV, Folli C, Marchetti C, Romano L, Carpani D, Conese M, Zegarra-Moran O. Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-g. Am J Physiol 2000;278:L1186-L1194.
12. Galietta LJV, Pagesy P, Folli C, Caci E, Romio L, Costes B, Nicolis E, Cabrini G, Goossens M, Ravazzolo R, et al. IL-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J Immunol 2002;168:839-845.
13. Zegarra-Moran O, Romio L, Folli C, Caci E, Becq F, Vierfond JM, Mettey Y, Cabrini G, Fanen P, Galietta LJ. Correction of G551D- CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07. Br J Pharmacol 2002;137:504-512.
14. Jasti J, Furukawa H, Gonzales E, Gouaux E. Structure of acid-sensing ion channel 1 at 1.9 a resolution and low ph. Nature 2007;449:316-323.
15. Canessa CM, Horisberger JD, Rossier BC. Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 1993;361: 467-470.
16. Hummler E, Horisberger JD. Genetic disorders of membrane transport: V. The epithelial sodium channel and its implication in human diseases. Am J Physiol 1999;276:G567-G571.
17. Rossier BC, Pradervand S, Schild L, Hummler E. Epithelial sodium channel and the control of sodium balance: Interaction between genetic and environmental factors. Annu Rev Physiol 2002;64:877-897.
18. Escoubet B, Coureau C, Bonvalet JP, Farman N. Noncoordinate regulation of epithelial Na channel and Na pump subunit mRNAs in kidney and colon by aldosterone. Am J Physiol 1997;272:C1482-C1491.
19. + channel along rat respiratory tract. Am J Physiol 1997;272:C131-C141.
20. Lazrak A, Samanta A, Venetsanou K, Barbry P, Matalon S. Modification of biophysical properties of lung epithelial Na(+ ) channels by dexamethasone. Am J Physiol Cell Physiol 2000;279:C762-C770.
21. Jain L, Chen XJ, Ramosevac S, Brown LA, Eaton DC. Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions. Am J Physiol Lung Cell Mol Physiol 2001;280: L646-L658.
22. Jain L, Chen XJ, Malik B, Al-Khalili O, Eaton DC. Antisense oligonucleotides against the alpha-subunit of ENaC decrease lung epithelial cation-channel activity. Am J Physiol 1999;276:L1046- L1051.
23. Burch LH, Talbot CR, Knowles MR, Canessa CM, Rossier BC, Boucher RC. Relative expression of the human epithelial Na+ channel subunits in normal and cystic fibrosis airways. Am J Physiol 1995; 269:C511-C518.
24. Russell JM. Sodium-potassium-chloride cotransport. Physiol Rev 2000; 80:211-276.
25. Li T, Folkesson HG. RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo. Am J Physiol Lung Cell Mol Physiol 2006; 290:L649-L660.
26. Li T, Koshy S, Folkesson HG. Involvement of falphagENaC and Nedd4-2 in the conversion from lung fluid secretion to fluid absorption at birth in the rat as assayed by RNA interference analysis. Am J Physiol Lung Cell Mol Physiol 2007;293:L1069-L1078.
27. Griesenbach U, Kitson C, Escudero Garcia S, Farley R, Singh C, Somerton L, Painter H, Smith RL, Gill DR, Hyde SC, et al. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir Res 2006;7:26.
28. Boucher RC. Status of gene therapy for cystic fibrosis lung disease. J Clin Invest 1999;103:441-445.